학술논문

E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial
Document Type
Article
Source
In: Leukemia. (Leukemia, December 2023, 37(12):2512-2516)
Subject
Language
English
ISSN
14765551
08876924